Carregant...
CDK1/2/5 blockade: killing two birds with one stone
Pancreatic ductal adenocarcinoma (PDAC) is an immune resistant tumor. We recently demonstrated that inhibiting CDK1/2/5 by dinaciclib not only blocks immune checkpoint expression, but also triggers histone-dependent immunogenic cell death. This dual mechanism turns immunologically “cold” tumor micro...
Guardat en:
| Publicat a: | Oncoimmunology |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7833763/ https://ncbi.nlm.nih.gov/pubmed/33537177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1875612 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|